Cancer Is One Of The Most Expensive Disease, And It Is Becoming More And More Expensive

Cancer Is One Of The Most Expensive Disease, And It Is Becoming More And More Expensive.
Millions of Americans with a recapitulation of cancer, uniquely common man under age 65, are delaying or skimping on medical care because of worries about the fetch of treatment, a new study suggests. The finding raises troubling questions about the long-term survival and mark of life of the 12 million adults in the United States whose lives have been forever changed by a diagnosis of cancer. "I mark it's concerning because we recognize that cancer survivors have many medical needs that linger for years after their diagnosis and treatment," said study lead inventor Kathryn E Weaver, an assistant professor in the Department of Social Sciences & Health Policy at Wake Forest University Baptist Medical Center in Winston-Salem, NC.

The explosion was published online June 14 in Cancer, a memoir of the American Cancer Society. Cost concerns have posed a risk to cancer survivorship for some time, particularly with the advent of new, life-prolonging treatments. Dr Patricia Ganz, a professor in the Department of Health Services at the University of California, Los Angeles School of Public Health, served on the Institute of Medicine commission that wrote the 2005 report, From Cancer Patient to Cancer Survivor: Lost in Transition. "One of the things that we in effect emphasized was shortage of insurance, strikingly for follow-up care".

CancerCare, a New York City-based nonprofit champion group for cancer patients, provides co-payment assistance for assured cancer medications. "Cancer is a vey expensive disease and it's becoming more and more expensive," said Jeanie M Barnett, CancerCare's maestro of communications. "The costs of the drugs are wealthy up. So, too, is the proportion that the patient pays out of pocket".

A March 17 commentary in the Journal of the American Medical Association, titled "Cancer's Next Frontier - Addressing High and Increasing Costs," reported that the unreflected costs of cancer had swelled from $27 billion in 1990 to more than $90 billion in 2008.